Spotlight on
Frontiers Health feature banner
Sponsored

Spotlight on Frontiers Health 2024

We’re excited to announce that Frontiers Health will be back 17th-18th October in Berlin, where it all began in 2016, and will bring together hund

Oncology
Paul Burton interview with Jonah Comstock

ASCO 2024 - Paul Burton

For Amgen, ASCO 2024 was all about lung cancer, with encouraging data in both non-small cell and small cell lung cancer.

Featured Content

R&D
pharmaphorum podcast Episode 137a

Global medicines and the future outlook

In a conversation held earlier in the year as the four-year anniversary of the pandemic approached, the pharmaphorum podcast had as guest Murray Aitken, executive director of the

Oncology
Paul Burton interview with Jonah Comstock

ASCO 2024 - Paul Burton

For Amgen, ASCO 2024 was all about lung cancer, with encouraging data in both non-small cell and small cell lung cancer.

Sales & Marketing
Launch Excellence: Moments of Truth
Sponsored

Launch Excellence: Moments of Truth

The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.

Newsletters and Deep Dive
digital magazine

Latest News

News
Augtyro

FDA widens label for BMS’ cancer drug Augtyro

Bristol-Myers Squibb has claimed FDA approval for a new, tumour-agnostic indication for Augtyro, the cancer drug it acquired as part of its $4.1 billion takeover of Turning Point Therapeuti

Views & Analysis

Oncology
Paul Burton interview with Jonah Comstock

ASCO 2024 - Paul Burton

For Amgen, ASCO 2024 was all about lung cancer, with encouraging data in both non-small cell and small cell lung cancer.

Spotlight on
Frontiers Health feature banner
Sponsored

Spotlight on Frontiers Health 2024

We’re excited to announce that Frontiers Health will be back 17th-18th October in Berlin, where it all began in 2016, and will bring together hund

Deep Dive

White Papers & Webinar

Sales & Marketing
Launch Excellence: Moments of Truth
Sponsored

Launch Excellence: Moments of Truth

The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.

Podcasts & Video

Oncology
Paul Burton interview with Jonah Comstock

ASCO 2024 - Paul Burton

For Amgen, ASCO 2024 was all about lung cancer, with encouraging data in both non-small cell and small cell lung cancer.

R&D
pharmaphorum podcast Episode 137a

Global medicines and the future outlook

In a conversation held earlier in the year as the four-year anniversary of the pandemic approached, the pharmaphorum podcast had as guest Murray Aitken, executive director of the

R&D
Dr Suzanne Trudel at ASCO 2024

ASCO 2024 - Suzanne Trudel

Sometimes getting a new drug to market is a relatively straight line, but sometimes it’s a winding road.

Partner Content

R&D
6th RAS-Targeted Drug Development Summit banner
Partner Content

6th RAS-Targeted Drug Development Summit

Overcome Diverse Clinical Resistance Mechanisms with Emerging First- & Best-In-Class Combination & Monotherapies to Effectively Treat Patients with RA

R&D
12th IMPACCT Real World Evidence Summit banner
Partner Content

12th IMPACCT Real World Evidence Summit

The 12th IMPACCT Real World Evidence Summit is the only industry meeting dedicated to uniting experts in RWE and Evidence Generation to consolidate, innovate and apply RWE across the drug developme

R&D
Wearable Injectors and Connected Devices UK conference banner
Partner Content

Wearable Injectors and Connected Devices UK

SAE Media Group’s 5th Annual Wearable Injectors and Connected Devices Conference will explore on-body device design and development whilst also engaging in the latest advances in connectivity and d

R&D
Pre-Filled Syringes Connect event banner
Partner Content

Pre-Filled Syringes Connect

SAE Media Group are proud to announce the inaugural Pre-Filled Syringes Connect event taking place on the 11th and 12th of September in Boston.